论文部分内容阅读
目的探究曲美他嗪联合阿托伐他汀治疗冠心病的临床效果。方法选取66例冠心病患者作为研究对象，并随机分为观察组和对照组。在常规治疗的基础上再给予对照组阿托伐他汀治疗，观察组则使用曲美他嗪联合阿托伐他汀治疗，比较两组的临床疗效，心绞痛发生次数和持续时间，血脂各指标变化及不良反应情况。结果观察组的治疗总有效率(87.88%)明显优于对照组(66.67%)；观察组心绞痛每周发生次数、持续时间均少于对照组，血脂各指标的改善情况也优于对照组，两组以上指标差异均具有统计学意义(0.05)。结论给予冠心病患者应用曲美他嗪与阿托伐他汀联合治疗的方式，能有效改善血脂指标，疗效显著，值得推广。“,”Objective To explore the trimetazidine joint atorvastatin clinical ef ect for the treatment of coronary heart disease (CHD). Methods Select 66 cases of coronary heart disease patients as the research object,and randomly divided into observation group and control group.Again on the basis of conventional treatment to the control group,atorvastatin treatment group use the trimetazidine joint atorvastatin treatment,compared two groups of clinical curative ef ect of angina frequency and duration, blood lipid changes and adverse reactions of various indicators.Results Treatment group total ef ective rate (87.88%) was bet er than control group (66.67%).Anginal happen every week,the duration of the observation group were less than the control group, the index of blood to improve the situation is bet er than control group,two groups of the above index dif erences are statistical y significant ( 0.05). Conclusion Trimetazidine for coronary heart disease (CHD) patients with atorvastatin treatment, can ef ectively improve blood lipid index,curative ef ect is distinct,and less adverse reaction, is safe and ef ective,is worth promoting.